SCHEMBL8281167

SCHEMBL8281167

Nc1ccc(C(=O)C(F)(F)F)cc1F

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.58
HDAC6 Q9UBN7 1/20 0.58
CES1 P23141 2/20 0.45
ALDH1A1 P00352 1/20 0.43
ACHE P22303 2/20 0.43
CES2 O00748 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40
CA5A P35218 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
CA5B Q9Y2D0 1/20 0.40
MLYCD O95822 5/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15920928 0.82 CES1 (0.61) CES1ACHECES2MLYCD
SCHEMBL863794 0.79 HDAC1 (0.66) HDAC1HDAC6CES1ALDH1A1CES2
SCHEMBL1851154 0.79 CES1 (0.44) HDAC1HDAC6CES1ACHECA12
SCHEMBL30351160 0.79 CES1 (0.44) HDAC1HDAC6CES1ACHECA12
SCHEMBL19306517 0.79 ACHE (0.46) CES1ALDH1A1ACHEMLYCD
SCHEMBL24346277 0.79 ALDH1A1 (0.49) CES1ALDH1A1ACHECA12CA1
SCHEMBL13885100 0.78 SNCA (0.50) CES1ACHECES2
SCHEMBL97816 0.78 HDAC1 (0.63) HDAC1HDAC6CES1ALDH1A1CES2
SCHEMBL28662791 0.78 HDAC1 (0.53) HDAC1HDAC6CES1ACHECES2
SCHEMBL1627106 0.78 HDAC1 (0.63) HDAC1HDAC6CES1ALDH1A1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745047-B1 PYRAZOLO[4,3-E]-1,2,4-TRIAZOLO[1,5-C]PYRIMIDINE ADENOSINE-A2A- RECEPTOR ANTAGONISTS SCHERING CORP (US) 2010-03-24 EP disclosed
EP-1622912-B1 2-ALKYNYL-AND 2-ALKENYL-PYRAZOLO- [4,3-E ] -1,2,4-TRIAZOLO- [1,5-C] -PYRIMIDINE ADENOSINE A2A RECEPTOR ANTAGONISTS SCHERING CORP (US) 2009-05-27 EP disclosed
WO-2005103055-A1 PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PYRIMIDINE ADENOSINE A2A RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2005-11-03 WO disclosed